| payload |
{"created_at":"2026-04-14T12:12:32.185 {"created_at":"2026-04-14T12:12:32.185628+00:00","dedupe_key":"signal_enriched:discovery_ipo_delta:58b755914b383258","evidence_event_ids":["evt_a2dfa7b2f3cd"],"signal_type":"discovery_ipo_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxONEQwVmxuRHZVOGloZER1Si1BT0ppNjhITlluYk9xdm41MVdTclI3WWFRX09OZ05OWU1XYTgzWDY4WDFDbG9ORFNrWUZOTlBYZjRjZEQ2aTh1ekRKR0tWc3h0ZGNWdlIzQzVKTXlsZFRqRGdqbGRjTmF1VTlibkZFbFFBNTRWWEt6RDM3cDNXakNTbzU0TWU3RTBoaUdrSnVGWmJqcUV2ODFxeTFG?oc=5","as_of":"2026-04-14T12:12:32.185628+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxONEQwVmxuRHZVOGloZER1Si1BT0ppNjhITlluYk9xdm41MVdTclI3WWFRX09OZ05OWU1XYTgzWDY4WDFDbG9ORFNrWUZOTlBYZjRjZEQ2aTh1ekRKR0tWc3h0ZGNWdlIzQzVKTXlsZFRqRGdqbGRjTmF1VTlibkZFbFFBNTRWWEt6RDM3cDNXakNTbzU0TWU3RTBoaUdrSnVGWmJqcUV2ODFxeTFG?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_936f77146a89b959","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-14T12:18:41.549568+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxONEQwVmxuRHZVOGloZER1Si1BT0ppNjhITlluYk9xdm41MVdTclI3WWFRX09OZ05OWU1XYTgzWDY4WDFDbG9ORFNrWUZOTlBYZjRjZEQ2aTh1ekRKR0tWc3h0ZGNWdlIzQzVKTXlsZFRqRGdqbGRjTmF1VTlibkZFbFFBNTRWWEt6RDM3cDNXakNTbzU0TWU3RTBoaUdrSnVGWmJqcUV2ODFxeTFG?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxONEQwVmxuRHZVOGloZER1Si1BT0ppNjhITlluYk9xdm41MVdTclI3WWFRX09OZ05OWU1XYTgzWDY4WDFDbG9ORFNrWUZOTlBYZjRjZEQ2aTh1ekRKR0tWc3h0ZGNWdlIzQzVKTXlsZFRqRGdqbGRjTmF1VTlibkZFbFFBNTRWWEt6RDM3cDNXakNTbzU0TWU3RTBoaUdrSnVGWmJqcUV2ODFxeTFG?oc=5","source_event_id":"evt_a2dfa7b2f3cd","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"f5a113dfe29ff51e","kind":"ipo_calendar","published_at":"2026-04-14T11:48:15+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.6,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Alamar Biosciences","relevance":"primary","symbol":"","type":"company"}],"event_type":"listing","information_gaps":["No IPO filing date is provided.","No exchange, ticker symbol, offering size, pricing range, or underwriters are provided.","No details on the \u201copening life sciences funding window\u201d (e.g., specific investors, programs, or metrics) are provided.","No article body text is available to verify or expand on the headline claims."],"key_facts":["Fierce Biotech reports that Alamar Biosciences has filed for an IPO.","The report characterizes the timing as occurring amid an opening life sciences funding window."],"numeric_claims":[],"primary_claim":"Alamar Biosciences filed for an IPO.","relevance_score":0.55,"sentiment":"neutral","source_quality":"unknown","summary":"Alamar Biosciences has filed for an IPO, according to Fierce Biotech. The report frames the filing as occurring amid an opening life sciences funding window, but no further IPO details are provided in the available text.","topics":["IPO filing","life sciences funding window"]},"source":"Fierce Biotech","source_domain":"gstatic.com","summary":"Alamar Biosciences files for IPO amid opening life sciences funding window Fierce Biotech","tickers":[],"title":"Alamar Biosciences files for IPO amid opening life sciences funding window - Fierce Biotech","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp"}}... |